First Time Loading...

Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211

Watchlist Manager
Tibet Rhodiola Pharmaceutical Holding Co Logo
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Watchlist
Price: 44.77 CNY -0.62% Market Closed
Updated: Mar 28, 2024

Intrinsic Value

Tibet Rhodiola Pharmaceutical Holding Co. engages in the manufacture and wholesale of pharmaceutical products. [ Read More ]

The intrinsic value of one Tibet Rhodiola Pharmaceutical Holding Co stock under the Base Case scenario is 88.66 CNY. Compared to the current market price of 44.77 CNY, Tibet Rhodiola Pharmaceutical Holding Co is Undervalued by 50%.

Key Points:
Intrinsic Value
Base Case
88.66 CNY
Undervaluation 50%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Tibet Rhodiola Pharmaceutical Holding Co

Backtest Tibet Rhodiola Pharmaceutical Holding Co Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Tibet Rhodiola Pharmaceutical Holding Co stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Tibet Rhodiola Pharmaceutical Holding Co's business.

What risks and challenges
does Tibet Rhodiola Pharmaceutical Holding Co face in the near future?

Summarize the latest earnings report
of Tibet Rhodiola Pharmaceutical Holding Co.

Provide P/E
for Tibet Rhodiola Pharmaceutical Holding Co and its competitors.

Financials

Balance Sheet Decomposition
Tibet Rhodiola Pharmaceutical Holding Co

Current Assets 3.5B
Cash & Short-Term Investments 2B
Receivables 895.6m
Other Current Assets 590.6m
Non-Current Assets 1.4B
Long-Term Investments 260.9m
PP&E 606.5m
Intangibles 425.5m
Other Non-Current Assets 78.1m
Current Liabilities 1.3B
Accounts Payable 43.2m
Accrued Liabilities 49.3m
Short-Term Debt 628.9m
Other Current Liabilities 598.2m
Non-Current Liabilities 65.6m
Long-Term Debt 1m
Other Non-Current Liabilities 64.6m
Efficiency

Earnings Waterfall
Tibet Rhodiola Pharmaceutical Holding Co

Revenue
3B CNY
Cost of Revenue
-186.5m CNY
Gross Profit
2.8B CNY
Operating Expenses
-1.9B CNY
Operating Income
856.9m CNY
Other Expenses
-74.5m CNY
Net Income
782.4m CNY

Free Cash Flow Analysis
Tibet Rhodiola Pharmaceutical Holding Co

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Tibet Rhodiola Pharmaceutical Holding Co's profitability score is 70/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
70/100
Profitability
Score

Tibet Rhodiola Pharmaceutical Holding Co's profitability score is 70/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Tibet Rhodiola Pharmaceutical Holding Co's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Negative Net Debt
80/100
Solvency
Score

Tibet Rhodiola Pharmaceutical Holding Co's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Tibet Rhodiola Pharmaceutical Holding Co

Wall Street analysts forecast Tibet Rhodiola Pharmaceutical Holding Co stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tibet Rhodiola Pharmaceutical Holding Co is 59.2 CNY .

Lowest
Price Target
Not Available
Average
Price Target
59.2 CNY
32% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Tibet Rhodiola Pharmaceutical Holding Co

1M 1M
+1%
6M 6M
-11%
1Y 1Y
-11%
3Y 3Y
-5%
5Y 5Y
+69%
10Y 10Y
+219%
Annual Price Range
44.77
52w Low
37.28
52w High
63.87
Price Metrics
Average Annual Return 34.16%
Standard Deviation of Annual Returns 115.08%
Max Drawdown -82%
Shares Statistics
Market Capitalization 11.1B CNY
Shares Outstanding 247 938 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Tibet Rhodiola Pharmaceutical Holding Co Logo
Tibet Rhodiola Pharmaceutical Holding Co

Country

China

Industry

Health Care

Market Cap

11.1B CNY

Dividend Yield

4.16%

Description

Tibet Rhodiola Pharmaceutical Holding Co. engages in the manufacture and wholesale of pharmaceutical products. The company is headquartered in Lhasa, Xizang and currently employs 733 full-time employees. The firm operates its businesses through the distribution of proprietary drug products, as well as the processing of pharmaceuticals and others. The firm conducts its businesses primarily in South China, North China, East China, Central China and overseas markets.

Contact

XIZANG
Lhasa
No. 19, Beijing Middle Road
+868916835809
http://www.xzyy.cn

IPO

1999-07-21

Employees

733

Officers

GM & Director
Mr. Yuan Dong Guo
Financial Director
Mr. Jun Chen
Deputy GM & Secretary of the Board
Ms. Lan Liu

See Also

Discover More
What is the Intrinsic Value of one Tibet Rhodiola Pharmaceutical Holding Co stock?

The intrinsic value of one Tibet Rhodiola Pharmaceutical Holding Co stock under the Base Case scenario is 88.66 CNY.

Is Tibet Rhodiola Pharmaceutical Holding Co stock undervalued or overvalued?

Compared to the current market price of 44.77 CNY, Tibet Rhodiola Pharmaceutical Holding Co is Undervalued by 50%.